Continuing our latest video series, BCL partner John Binns give a brief overview of the legal state of the UK's cannabis industry and how the trends of 2019 might develop through 2020.

Recently, President Joe Biden signed the Medical Marijuana and Cannabidiol Research Expansion Act, which provides a mechanism...

Lawful cannabis businesses are active in several jurisdictions outside the UK like Canada and various states of the USA, however it is still heavily restricted in the UK and this has caused private investors...

AlixPartners is pleased to welcome Julian Gething to the UK Turnaround and Restructuring Team. Julian, alongside colleagues Anthony Place and Esben Christensen...

On November 19, 2020, the Court of Justice for the European Union determined cannabidiol (CBD) derived from the entire cannabis plant is a lawful product, greatly expanding opportunities for CBD...

Debate and controversy around cannabis and its derivatives are nothing new, with a wide array of legal frameworks and restrictions on its use in place around the world.

BCL Senior Associate, David Hardstaff and Partner, John Binns write for Open Access Government exploring the UK's doomed Medical Cannabis Bill.

A UK government taskforce has called for reform to UK medical cannabis regulations, which could significantly boost the UK's medical cannabis industry.

BCL partner John Binns writes for Open Access Government on the future developments UK legal cannabis industry, including legal, cultural and political challenges.

In a recent decision of the General Court of the European Union (Santa Conte v. EUIPO, Case T-683/18), the Court was asked to consider in what circumstances a trade mark containing the...

The Food Standards Agency (FSA), which regulates foods and food businesses in England, Wales and Northern Ireland, yesterday issued its long awaited statement on CBD in foods.

The BBC's ‘Good Food' publication reported earlier this year that Cannabidiol (CBD) is becoming increasingly popular in the health world. It is sourced from the cannabis...

On 31 March 2022, the Food Standards Agency (FSA) published the list of cannabinoid (CBD) containing food products that have a credible application for novel food authorisation pending with the FSA.

On 4 October 2023, the government published its plans for a consultation relating to proposed new regulations governing the sale and marketing of vaping products.

The manufacture, marketing and supply of medicinal cannabis products raise complex regulatory issues in the jurisdiction where those activities take place.

UK food safety watchdog issues warning to CBD businesses that their products could be ‘taken off the shelves' if the industry fails to submit valid novel food authorisation applications by 31 March 2021.

Near the end of a cold, grim January in the UK, the Minister of State for Crime and Policing, Kit Malthouse MP, wrote to the Advisory Council on the Misuse of Drugs.

Three fire risks are quietly reshaping the UK property insurance market, and each is moving faster than the industry’s response to it. Ageing solar installations, lithium-ion battery fires and butane hash oil explosions linked to organised crime are generating losses of a size and complexity that current policy wordings and underwriting assumptions were not designed to address.

Businesses that work in the cannabis industry are accustomed to regulatory issues, but the UK's rules are both stricter than those of other jurisdictions, and more complicated than they need to be.

BCL partner John Binns and associate David Hardstaff ask if a new report should put a spring in the step of UK businesses with an interest in medicinal cannabis and cannabidiol (CBD)...